Sativex PK in mild to severe oral mucositis

• Research type

  Research Study

• Full title

  An open-label clinical trial to compare the pharmacokinetics of up to 4 single oromucosal doses of 4 sprays of Sativex® in patients with treatment induced mild, moderate and severe oral mucositis (grade 1 - 3 rtog oral mucositis) with their pharmacokinetic profile pre-treatment (when mucositis-free)

• IRAS ID

  134739

• Contact name

  James Ritter

• Contact email

  james.ritter@quintiles.com

• Sponsor organisation

  GW Pharma Ltd

• Eudract number

  2013-001957-29

• REC name

  HSC REC B

• REC reference

  13/NI/0145

• Date of REC Opinion

  14 Oct 2013

• REC opinion

  Further Information Favourable Opinion